Ovarian Cancer Treatment in Lucknow
Specialist Care at Lucknow Cancer Institute
Ovarian cancer starts in the ovaries, the organs that produce eggs and female hormones. It is often called a "silent" cancer because early symptoms can be vague and easily missed. At Lucknow Cancer Institute, Dr. Sidharth Pant offers comprehensive care for ovarian cancer, from diagnosis and staging to surgery planning, chemotherapy and long‑term follow‑up.
How Common Is Ovarian Cancer?
Understanding the global and Indian epidemiology of ovarian cancer
Geographic Variation
Higher Incidence:
- North America (~9.4 per 100,000)
- Europe (~8.3 per 100,000)
- Australia/New Zealand (~7.8 per 100,000)
Lower Incidence:
- Africa (~3.4 per 100,000)
- Asia (~4.4 per 100,000)
Age & Demographics
- Peak incidence: 60–64 years, median age around 63
- Post‑menopausal women: About 70% of cases
- Higher incidence in: White women (~8.8 per 100,000)
- Higher risk: Women with strong family history of ovarian or breast cancer
- Risk increases significantly with age
Types & Staging
Understanding the different types and stages of ovarian cancer
Types of Ovarian Cancer
Epithelial Ovarian Cancer (≈90%)
Starts in the outer lining of the ovary; most common type in adults.
Germ Cell Ovarian Cancer (≈5%)
Arises from the egg‑forming cells; more common in younger women.
Stromal Ovarian Cancer (≈5%)
Develops from hormone‑producing and supporting tissue of the ovary; can cause hormone‑related symptoms.
Stages of Ovarian Cancer
Stage I
Cancer confined to one or both ovaries.
Stage II
Cancer has spread to pelvic organs (uterus, fallopian tubes, bladder, rectum).
Stage III
Cancer has spread within the abdomen (peritoneum, omentum, lymph nodes).
Stage IV
Cancer has spread to distant organs (lungs, liver parenchyma, outside abdomen).
Staging is usually confirmed after surgery and detailed pathological examination.
Symptoms & When to Worry
Early detection can significantly improve treatment outcomes
Symptoms of Ovarian Cancer
Early ovarian cancer may have no clear symptoms, or symptoms may be subtle and mistaken for gas or indigestion. Seek evaluation if the following are new, frequent, or persistent:
Important Alert
If these symptoms occur more than 12 days a month for several weeks, they should not be ignored. Early consultation can make a significant difference in treatment outcomes.
Who Is at Higher Risk?
Understanding risk factors for ovarian cancer
Genetic & Family Factors
- BRCA1 and BRCA2 gene mutations significantly increase risk
- History of ovarian, breast, or certain other cancers in close relatives
- Lynch syndrome and other hereditary cancer syndromes
- Family history of ovarian/breast cancer in first-degree relatives
Age & Reproductive Factors
- Risk increases with age; peak in women 60–64 years
- Never having been pregnant (nulliparity)
- Early onset of periods (early menarche)
- Late menopause
- Long‑term hormone replacement therapy in some settings
Lifestyle & Other Factors
- Obesity and sedentary lifestyle
- Endometriosis in some cases
- Smoking (linked to mucinous ovarian cancer)
- Tall height and high body mass index
Protective Factors
- Use of oral contraceptive pills for several years
- Multiple pregnancies and breastfeeding
- Tubal ligation or removal of ovaries in high‑risk women
- Healthy weight maintenance
Genetic Counseling
Women with strong family history or known gene mutations may benefit from genetic counselling and risk‑reduction strategies. Early screening and preventive measures can significantly reduce risk.
Diagnosis & Work‑up
Comprehensive evaluation for accurate diagnosis and staging
Clinical Evaluation
Detailed history of symptoms, family history, menstrual/reproductive history. Pelvic examination to feel for masses or fluid.
Imaging Studies
Pelvic ultrasound (TVS) – first‑line to evaluate ovarian masses. CT scan / MRI of abdomen & pelvis – to assess spread. Chest imaging – to rule out metastases.
Blood Tests
Tumour markers such as CA‑125, and sometimes HE4 and others. Complete blood counts, liver and kidney function tests.
Definitive Diagnosis & Staging Surgery
Usually made after surgery to remove the tumour. Includes assessment of ovaries, uterus, omentum, lymph nodes and peritoneal surfaces. Peritoneal washings and multiple biopsies help determine exact stage.
Multidisciplinary Treatment Approach
Comprehensive care at Lucknow Cancer Institute
1. Surgery
Primary Cytoreductive (Debulking) Surgery
Goal is to remove all visible tumour or reduce it to minimal residual disease. May include removal of ovaries, uterus, omentum and involved peritoneal deposits.
Interval Cytoreductive Surgery
Performed after a few cycles of neoadjuvant chemotherapy in advanced, bulky disease where primary surgery is not safe or feasible.
2. Chemotherapy
Standard First‑Line Regimen
Platinum‑based combination chemotherapy (e.g., carboplatin with paclitaxel). Given as adjuvant therapy (after surgery) in early and advanced stages.
Neoadjuvant Therapy
Given before surgery in very advanced or medically unfit patients to shrink disease and make surgery safer.
3. Targeted & Maintenance Therapy
PARP Inhibitors
For patients with BRCA mutations or homologous recombination deficiency after first‑line chemotherapy.
Anti‑Angiogenic Agents
May be used in certain advanced cases to slow tumour growth.
4. Supportive & Palliative Care
Symptom Management
Management of treatment‑related side effects, ascites, pain and bowel obstruction.
Quality of Life
Nutritional support, psychological counselling and comprehensive symptom control.
Multidisciplinary Team
Management of ovarian cancer requires close coordination between surgical oncologists, medical oncologists, gynecologic oncologists, pathologists, radiologists, and palliative care specialists for optimal outcomes.
Follow‑up & Survivorship
Comprehensive care continues after treatment completion
Follow‑up After Treatment
- Clinical visits: Every 3–6 months initially, then yearly
- Physical examination: Comprehensive evaluation at each visit
- CA‑125 monitoring: Where it was elevated at diagnosis
- Imaging: Ultrasound/CT as clinically indicated
- Health assessment: Menopausal symptoms, bone health and cardiovascular risk management
- Lifestyle guidance: Physical activity, nutrition and emotional well‑being
Living With and Beyond Ovarian Cancer
- Many women return to normal or near‑normal life after treatment
- Support groups and counselling for coping with fear of recurrence
- Addressing body image issues and sexual health concerns
- Fertility preservation discussions for younger patients
- High‑risk family members offered genetic counselling and screening
- Long‑term survivorship care plans tailored to individual needs
When to Seek a Second Opinion
A second opinion can provide clarity and confidence in your treatment plan
Second Opinion for Ovarian Cancer
A second opinion can be helpful in the following situations:
New Diagnosis Confirmation
You have been newly diagnosed and want to confirm the stage and best treatment plan.
Surgical Options Clarification
Surgery has been advised and you wish to know if neoadjuvant chemotherapy is an option.
Recurrent Disease Management
The cancer has recurred and you want to explore further chemotherapy, targeted therapy or clinical trials.
Treatment Decision Support
You are unsure about the benefits versus side effects of continuing treatment.
Dr. Sidharth Pant's Second Opinion Service
Dr. Sidharth Pant offers detailed second‑opinion consultations with review of reports, scans and pathology, and clear explanation of options in simple language.